A biotech company is suing to block Merck & Co. from launching an easier-to-use version of its blockbuster cancer treatment Keytruda, alleging the pharmaceutical giant violated its intellectual property.
Source link
2025-04-24
Welcome
A biotech company is suing to block Merck & Co. from launching an easier-to-use version of its blockbuster cancer treatment Keytruda, alleging the pharmaceutical giant violated its intellectual property.
Source link
Privacy Policy Designed using Magazine News Byte. Powered by WordPress.